Neuraxis, INC
Datakwaliteit: 100%
NRXS
NYSE
Manufacturing
Measuring & Analyzing Instruments
€ 7,22
▲
€ 0,12
(1,69%)
Marktkapitalisatie: 80,77 M
Prijs
€ 7,22
Marktkapitalisatie
80,77 M
Dagbereik
€ 6,97 — € 7,28
52-Weeksbereik
€ 1,33 — € 7,97
Volume
91.716
Openen € 7,11
50D / 200D Gem.
€ 5,80
24,41% above
50D / 200D Gem.
€ 3,65
97,86% above
Quick Summary
Belangrijkste Punten
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -6,46 M
Capital efficient — spends only 0,87% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)32,89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-238,61%
Onder sectorgemiddelde (-53,47%)
ROIC-160,94%
Net Margin-218,55%
Op. Margin-219,37%
Veiligheid
Debt / Equity
0,09
Onder sectorgemiddelde (0,31)
Current Ratio1,58
Interest Coverage-105,85
Waardering
PE (TTM)
-10,36
Onder sectorgemiddelde (-1,47)
P/B Ratio35,35
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,4 | -1,5 |
| P/B | 35,4 | 1,6 |
| ROE % | -238,6 | -53,5 |
| Net Margin % | -218,6 | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | 0,1 | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32,89% | Revenue Growth (3Y) | 20,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,57 M | Net Income (TTM) | -7,80 M |
| ROE | -238,61% | ROA | -121,27% |
| Gross Margin | 84,23% | Operating Margin | -219,37% |
| Net Margin | -218,55% | Free Cash Flow (TTM) | -6,46 M |
| ROIC | -160,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 1,58 |
| Interest Coverage | -105,85 | Asset Turnover | 0,55 |
| Working Capital | 1,84 M | Tangible Book Value | 2,00 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10,36 | Forward P/E | N/A |
| P/B Ratio | 35,35 | P/S Ratio | 22,63 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8,00% | ||
| Market Cap | 80,77 M | Enterprise Value | 76,59 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,95 | Revenue / Share | 0,32 |
| FCF / Share | -0,58 | OCF / Share | -0,58 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,87% | FCF Conversion | 82,87% |
| SBC-Adj. FCF | -6,90 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 3,57 M | 2,69 M | 2,46 M |
| Net Income | -7,80 M | -8,24 M | -14,63 M |
| EPS (Diluted) | -0,95 | -1,22 | -4,50 |
| Gross Profit | 3,01 M | 2,32 M | 2,16 M |
| Operating Income | -7,83 M | -7,16 M | -6,66 M |
| EBITDA | — | — | — |
| R&D Expenses | 493.611,0 | 206.107,0 | 169.315,0 |
| SG&A Expenses | — | — | — |
| D&A | 59.501,0 | 37.831,0 | 40.725,0 |
| Interest Expense | 73.969,0 | 174.328,0 | 476.416,0 |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 6,40 M | 4,76 M | 509.498,0 |
| Total Liabilities | 3,00 M | 2,69 M | 1,91 M |
| Shareholders' Equity | 3,40 M | 2,07 M | -1,40 M |
| Total Debt | 148.293,0 | 154.152,0 | 376.404,0 |
| Cash & Equivalents | 4,97 M | 3,70 M | 78.560,0 |
| Current Assets | 5,73 M | 4,27 M | 242.610,0 |
| Current Liabilities | 2,79 M | 2,43 M | 1,89 M |
{"event":"ticker_viewed","properties":{"ticker":"NRXS","listing_kind":"stock","pathname":"/stocks/nrxs","exchange":"NYSE","country":"US"}}